Quiz
L16 Therapeutics of Asthma
Dieses Quiz enthält Fragetypen, die sich im gewohnten Player öffnen.
Fragen in diesem Quiz (8)
1Clinical practice guidelines, meta-analysis, and systematic reviews are the highest ranked forms of evidence.
- ARichtig
- BFalsch
2Māori are 3.4 times, and Pacific peoples 3.9 times, more likely to be admitted to hospital with asthma than Europeans or other New Zealanders.
- ARichtig
- BFalsch
3When diagnosing asthma there is no single “gold standard” test, and we must assess the pattern of [blank_start]signs and symptoms[blank_end](wheezing, breathlessness, chest tightness, and coughing, particularly at [blank_start]night[blank_end] or [blank_start]early[blank_end] in the morning). We can also measure [blank_start]expiratory airflow[blank_end] on more than one occasion, and assess [blank_start]response[blank_end] to inhaled bronchodilator +/- inhaled corticosteroid.
- Asigns and symptoms
- Bnight
- Cearly
- Dexpiratory airflow
- Eresponse
4Ideal PEFR values depend on height and sex.
- ARichtig
- BFalsch
5Which of these is NOT a principle of asthma treatment?
- AAvoid triggers
- BMaking an asthma plan
- CDrugs to improve ventilation
- DDrugs to decrease inflammation
- EAvoid exercise
6Goals of asthma treatment are about maintaining long-term control using the [blank_start]least[blank_end] amount of medications and [blank_start]minimising[blank_end] adverse effects.
We want to prevent chronic [blank_start]symptoms[blank_end], require infrequent use ([blank_start]2[blank_end] or fewer days/week) of SABA, maintain normal or near-normal [blank_start]pulmonary[blank_end] function and maintain [blank_start]activity[blank_end] levels. We should assure patients’ and families’ [blank_start]satisfaction[blank_end] with asthma care. We also want to prevent exacerbations, the need for [blank_start]hospitalisation[blank_end], and prevent progressive [blank_start]loss[blank_end] of lung function.- Aleast
- Bminimising
- Csymptoms
- D2
- Epulmonary
- Factivity
- Gsatisfaction
- Hhospitalisation
- Iloss
7Which of these is not a drug delivery device?
- ASoft mist inhaler (SMI) - only with LAMA products in NZ
- BNebuliser
- CDry power inhaler (DPI)
- DMetered-dose inhaler (MDI) - spacer chamber
- EDry mist inhaler (DMI)
8Treatment steps:
1. At initial diagnosis, all patients should use a [blank_start]SABA[blank_end], as required..
2. Add an [blank_start]ICS[blank_end] if patients have symptoms for more than [blank_start]two[blank_end] weeks. Often a big decision! (The usual dose in adults is [blank_start]budesonide 400 mcg[blank_end]/day.)
3. If control is not adequate, [blank_start]ICS dose[blank_end] can be increased.
4. If control is not adequate, combine [blank_start]ICS with a LABA[blank_end]. ([blank_start]Formoterol+budesonide[blank_end] can be used as a preventer and replace SABA.)
Patients can step up or down in order to achieve and maintain control.
Check adherence and inhaler [blank_start]technique[blank_end] at each step of the way!- ASABA
- BICS
- Ctwo
- Dbudesonide 400 mcg
- EICS dose
- FICS with a LABA
- GFormoterol+budesonide
- Htechnique
Informationen
- Beschreibung
- Der Nutzer hat seine Fachbereichs-Information gelöscht. Quiz am L16 Therapeutics of Asthma, erstellt von Gelöschter Nutzer am 14/04/2019.
- Autor
- Gelöschter Nutzer
- Sprache
- English
- Aufrufe
- 57
- Verlauf
- Erstellt am 14 Apr 2019 · aktualisiert am 26 Mai 2019
- Schlagwörter
- Bewertung
- Noch keine Bewertungen Bewerte dieses Quiz